Literature DB >> 32143503

Cow Milk and Intestinal Epithelial Cell-derived Extracellular Vesicles as Systems for Enhancing Oral Drug Delivery.

Greta Carobolante1,2, Julia Mantaj1, Enrico Ferrari3, Driton Vllasaliu1.   

Abstract

Ingestion is the preferred way for drug administration. However, many drugs have poor oral bioavailability, warranting the use of injections. Extracellular vesicles (EVs) from cow milk have shown potential utility in improving oral drug bioavailability. However, EVs produced by intestinal epithelial cells have not been investigated for this application. We compared the capacity of cow milk EVs and intestinal epithelial cell-derived counterparts to enhance oral drug bioavailability. EVs were isolated, fluorescently labelled, and loaded with curcumin (CUR) as a model poorly absorbable drug. These were then characterised before testing in an intestinal model (Caco-2). Epithelial cell-derived EVs showed notably higher cell uptake compared to cow milk EVs. Cell uptake was significantly higher in differentiated compared to undifferentiated cells for both types of EVs. While both milk- and cell-derived EVs improved the cell uptake and intestinal permeability of CUR (confirming oral drug bioavailability enhancement potential), epithelial cell EVs demonstrated a superior effect.

Entities:  

Keywords:  drug absorption; exosomes; extracellular vesicles; intestinal permeability; oral drug bioavailability

Year:  2020        PMID: 32143503     DOI: 10.3390/pharmaceutics12030226

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  20 in total

Review 1.  Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement.

Authors:  Yuehong Ren; Linghui Nie; Shiping Zhu; Xingwang Zhang
Journal:  Int J Nanomedicine       Date:  2022-10-17

2.  Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA.

Authors:  Matthew R Warren; Chenzhen Zhang; Armin Vedadghavami; Krister Bokvist; Pradeep K Dhal; Ambika G Bajpayee
Journal:  Biomater Sci       Date:  2021-06-15       Impact factor: 7.590

Review 3.  Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation.

Authors:  Eleonore Fröhlich
Journal:  Pharmaceutics       Date:  2021-02-07       Impact factor: 6.321

Review 4.  Breast Milk: A Source of Functional Compounds with Potential Application in Nutrition and Therapy.

Authors:  Cristina Sánchez; Luis Franco; Patricia Regal; Alexandre Lamas; Alberto Cepeda; Cristina Fente
Journal:  Nutrients       Date:  2021-03-22       Impact factor: 5.717

5.  Overview and Update on Methods for Cargo Loading into Extracellular Vesicles.

Authors:  Yohan Han; Timothy W Jones; Saugata Dutta; Yin Zhu; Xiaoyun Wang; S Priya Narayanan; Susan C Fagan; Duo Zhang
Journal:  Processes (Basel)       Date:  2021-02-15       Impact factor: 2.847

6.  Non-Invasive Drug Delivery Systems.

Authors:  Driton Vllasaliu
Journal:  Pharmaceutics       Date:  2021-04-23       Impact factor: 6.321

Review 7.  Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment.

Authors:  Andrew E Massey; Shabnam Malik; Mohammad Sikander; Kyle A Doxtater; Manish K Tripathi; Sheema Khan; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan; Bilal B Hafeez
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

Review 8.  More than Nutrition: Therapeutic Potential of Breast Milk-Derived Exosomes in Cancer.

Authors:  Ki-Uk Kim; Wan-Hoon Kim; Chi Hwan Jeong; Dae Yong Yi; Hyeyoung Min
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

Review 9.  Milk Exosomes: Perspective Agents for Anticancer Drug Delivery.

Authors:  Sergey Sedykh; Anna Kuleshova; Georgy Nevinsky
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

Review 10.  Stem cells and exosomes: promising candidates for necrotizing enterocolitis therapy.

Authors:  Ruijie Zeng; Jinghua Wang; Zewei Zhuo; Yujun Luo; Weihong Sha; Hao Chen
Journal:  Stem Cell Res Ther       Date:  2021-06-05       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.